A new version of ResearchHub is available.Try it now
Paper
Document
Download
Flag content
0

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021

Published
Jan 7, 2022
Show more
Save
TipTip
Document
Download
Flag content
0
TipTip
Save
Document
Download
Flag content